{"id":"https://openalex.org/W7215220191","doi":null,"title":"Proteolysis-targeting chimeras (PROTACs): a review of their development and potential pharmacological applications","display_name":"Proteolysis-targeting chimeras (PROTACs): a review of their development and potential pharmacological applications","publication_year":2025,"publication_date":"2025-10-10","ids":{"openalex":"https://openalex.org/W7215220191"},"language":"en","primary_location":{"id":"pmh:oai:pharmakeftiki.hsmc.gr:article/275","doi":null,"is_oa":true,"landing_page_url":"https://pharmakeftiki.hsmc.gr/pj/article/view/275","pdf_url":"https://pharmakeftiki.hsmc.gr/pj/article/download/275/180","source":{"id":"https://openalex.org/S7407067120","display_name":"Pharmakeftiki","issn_l":"1105-4999","issn":["1105-4999"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1105-4999","raw_type":"info:eu-repo/semantics/article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://pharmakeftiki.hsmc.gr/pj/article/download/275/180","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5138940477","display_name":"Karrar Najeh Chfat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166455938","display_name":"University of Babylon","ror":"https://ror.org/0170edc15","country_code":"IQ","type":"education","lineage":["https://openalex.org/I166455938"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Chfat, Karrar Najeh","raw_affiliation_strings":["College of Pharmacy , University of Babylon , Hillah , Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Pharmacy , University of Babylon , Hillah , Iraq","institution_ids":["https://openalex.org/I166455938"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5154137462","display_name":"Shaker Awad Abdul Hussein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abdul Hussein, Shaker Awad","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.34671671,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/protacs","display_name":"PROTACs","score":0.8519999980926514},{"id":"https://openalex.org/keywords/targeted-protein-degradation","display_name":"targeted protein degradation","score":0.828000009059906},{"id":"https://openalex.org/keywords/e3-ubiquitin-ligase","display_name":"E3 ubiquitin ligase","score":0.843999981880188},{"id":"https://openalex.org/keywords/heterobifunctional-molecules","display_name":"heterobifunctional molecules","score":0.8889999985694885},{"id":"https://openalex.org/keywords/ubiquitination","display_name":"ubiquitination","score":0.7960000038146973},{"id":"https://openalex.org/keywords/proteasome","display_name":"proteasome","score":0.7699999809265137},{"id":"https://openalex.org/keywords/undruggable-proteins","display_name":"undruggable proteins","score":0.9380000233650208},{"id":"https://openalex.org/keywords/protac-design","display_name":"PROTAC design","score":0.7870000004768372},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9190000295639038},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.8199999928474426},{"id":"https://openalex.org/keywords/neurological-disorders","display_name":"neurological disorders","score":0.9620000123977661}],"concepts":[{"id":"https://openalex.org/C134459356","wikidata":"https://www.wikidata.org/wiki/Q4274835","display_name":"Ubiquitin ligase","level":4,"score":0.6035000085830688},{"id":"https://openalex.org/C25602115","wikidata":"https://www.wikidata.org/wiki/Q407111","display_name":"Ubiquitin","level":3,"score":0.5666999816894531},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.5098000168800354},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4569999873638153},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.4433000087738037},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4049000144004822},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.3804999887943268},{"id":"https://openalex.org/C175114707","wikidata":"https://www.wikidata.org/wiki/Q408483","display_name":"DNA ligase","level":3,"score":0.3747999966144562},{"id":"https://openalex.org/C2992195973","wikidata":"https://www.wikidata.org/wiki/Q33123","display_name":"Protein degradation","level":2,"score":0.3594000041484833},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3208000063896179},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.29510000348091125},{"id":"https://openalex.org/C133956753","wikidata":"https://www.wikidata.org/wiki/Q583864","display_name":"FKBP","level":2,"score":0.2948000133037567},{"id":"https://openalex.org/C2780430158","wikidata":"https://www.wikidata.org/wiki/Q7685902","display_name":"Target protein","level":3,"score":0.289000004529953},{"id":"https://openalex.org/C2908868211","wikidata":"https://www.wikidata.org/wiki/Q4274835","display_name":"Ubiquitin-Protein Ligases","level":5,"score":0.2856999933719635},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.27720001339912415},{"id":"https://openalex.org/C6856738","wikidata":"https://www.wikidata.org/wiki/Q331672","display_name":"Protein expression","level":3,"score":0.2660999894142151}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:pharmakeftiki.hsmc.gr:article/275","doi":null,"is_oa":true,"landing_page_url":"https://pharmakeftiki.hsmc.gr/pj/article/view/275","pdf_url":"https://pharmakeftiki.hsmc.gr/pj/article/download/275/180","source":{"id":"https://openalex.org/S7407067120","display_name":"Pharmakeftiki","issn_l":"1105-4999","issn":["1105-4999"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1105-4999","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:pharmakeftiki.hsmc.gr:article/275","doi":null,"is_oa":true,"landing_page_url":"https://pharmakeftiki.hsmc.gr/pj/article/view/275","pdf_url":"https://pharmakeftiki.hsmc.gr/pj/article/download/275/180","source":{"id":"https://openalex.org/S7407067120","display_name":"Pharmakeftiki","issn_l":"1105-4999","issn":["1105-4999"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1105-4999","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8999999761581421,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7215220191.pdf","grobid_xml":"https://content.openalex.org/works/W7215220191.grobid-xml"},"referenced_works_count":6,"referenced_works":["https://openalex.org/W2769590617","https://openalex.org/W2781383440","https://openalex.org/W2906814157","https://openalex.org/W3096395578","https://openalex.org/W4282964463","https://openalex.org/W4366695764"],"related_works":["https://openalex.org/W7220544678","https://openalex.org/W2912657221","https://openalex.org/W7127315969","https://openalex.org/W2792290561","https://openalex.org/W7128391827","https://openalex.org/W2936661052","https://openalex.org/W7161786695","https://openalex.org/W7211985486","https://openalex.org/W4282964463","https://openalex.org/W4413001817"],"abstract_inverted_index":{"Beyond":[0],"conventional":[1],"small-molecule":[2],"inhibitors,":[3],"proteolysis-targeting":[4],"chimeras":[5],"(PROTACs)":[6],"represent":[7],"a":[8,30],"novel":[9],"therapeutic":[10,146],"strategy":[11],"for":[12,106,117,132,151],"targeted":[13],"protein":[14,32,166],"degradation.":[15],"These":[16],"heterobifunctional":[17],"molecules":[18],"are":[19],"engineered":[20],"in":[21,84,100],"order":[22],"to":[23,29,52,55,96,138],"recruit":[24],"an":[25],"E3":[26,134],"ubiquitin":[27],"ligase":[28,135],"specific":[31],"of":[33,76,94,109,142,156],"interest,":[34],"thereby":[35],"facilitating":[36],"its":[37,53],"ubiquitination":[38],"and":[39,81,121,129,144,160],"subsequent":[40],"degradation":[41],"by":[42,164],"the":[43,73,85,92,104,130,153],"proteasome.":[44],"This":[45,70],"approach":[46],"has":[47],"garnered":[48],"significant":[49],"attention":[50],"due":[51],"ability":[54],"target":[56],"proteins":[57],"traditionally":[58],"considered":[59],"\u201cundruggable\u201d,":[60],"including":[61],"those":[62],"lacking":[63],"enzymatic":[64],"activity":[65],"or":[66],"accessible":[67],"binding":[68],"pockets.":[69],"mini-review":[71],"outlines":[72],"mechanistic":[74],"basis":[75],"PROTACs,":[77],"key":[78],"design":[79],"principles,":[80],"recent":[82],"advances":[83],"field.":[86],"Particular":[87],"emphasis":[88],"is":[89],"placed":[90],"on":[91],"potential":[93],"PROTACs":[95,148],"address":[97],"persistent":[98],"challenges":[99],"drug":[101],"discovery,":[102],"notably":[103],"need":[105,131],"selective":[107],"elimination":[108],"pathogenic":[110],"proteins.":[111],"The":[112],"review":[113],"also":[114],"explores":[115],"strategies":[116],"optimizing":[118],"PROTAC-based":[119],"therapies":[120],"discusses":[122],"current":[123],"limitations,":[124],"such":[125],"as":[126],"pharmacokinetic":[127],"constraints":[128],"improved":[133],"engagement.":[136],"Owing":[137],"their":[139],"distinctive":[140],"mode":[141],"action":[143],"expanding":[145],"scope,":[147],"hold":[149],"promise":[150],"transforming":[152],"treatment":[154],"landscape":[155],"cancer,":[157],"neurological":[158],"disorders,":[159],"other":[161],"diseases":[162],"driven":[163],"aberrant":[165],"expression.":[167]},"counts_by_year":[],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2026-10-02T00:00:00"}